Lipids: The Before-and-After Test
In the MACS cohort, key lipid levels declined between seroconversion and initiating combination therapy, then increased; ultimate levels did not differ significantly from those observed in the general population.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)